2020 Q4 Form 10-K Financial Statement

#000156459021017086 Filed on March 31, 2021

View on sec.gov

Income Statement

Concept 2020 Q4 2019 Q4 2019
Revenue $2.380M $2.230M $8.670M
YoY Change 6.73% 7.73% 6.89%
Cost Of Revenue $890.0K $870.0K $3.580M
YoY Change 2.3% 8.75% 9.82%
Gross Profit $1.490M $1.350M $5.090M
YoY Change 10.37% 6.3% 4.95%
Gross Profit Margin 62.61% 60.54% 58.71%
Selling, General & Admin $570.0K $480.0K $2.130M
YoY Change 18.75% 2.13% 16.39%
% of Gross Profit 38.26% 35.56% 41.85%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $460.0K $380.0K $1.440M
YoY Change 21.05% 8.57% 2.98%
% of Gross Profit 30.87% 28.15% 28.29%
Operating Expenses $1.030M $870.0K $7.267M
YoY Change 18.39% 4.82% 8.71%
Operating Profit $460.0K $480.0K $1.401M
YoY Change -4.17% 9.09% -1.74%
Interest Expense -$140.0K -$440.0K $1.076M
YoY Change -68.18% 120.0% 19.78%
% of Operating Profit -30.43% -91.67% 76.78%
Other Income/Expense, Net -$810.2K
YoY Change 0.51%
Pretax Income $320.0K $20.00K $590.0K
YoY Change 1500.0% -75.0% -4.84%
Income Tax
% Of Pretax Income
Net Earnings $320.0K $20.00K $590.6K
YoY Change 1500.0% -75.0% -4.65%
Net Earnings / Revenue 13.45% 0.9% 6.81%
Basic Earnings Per Share
Diluted Earnings Per Share $34.33K $2.535K $76.62K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding 7.702M

Balance Sheet

Concept 2020 Q4 2019 Q4 2019
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.610M $3.990M $3.990M
YoY Change -59.65% 160.78% 160.78%
Cash & Equivalents $1.615M $3.990M $3.990M
Short-Term Investments
Other Short-Term Assets $330.0K $290.0K $290.0K
YoY Change 13.79% 11.54% 11.54%
Inventory
Prepaid Expenses
Receivables $110.0K $160.0K $160.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $2.050M $4.440M $4.440M
YoY Change -53.83% 138.71% 138.71%
LONG-TERM ASSETS
Property, Plant & Equipment $59.79M $59.79M $59.79M
YoY Change 0.0% 11.11% 11.11%
Goodwill $694.1K $694.1K
YoY Change 0.0% 0.0%
Intangibles $398.8K
YoY Change
Long-Term Investments $1.920M $1.760M $1.760M
YoY Change 9.09% 12.1% 12.1%
Other Assets $490.0K $580.0K $580.0K
YoY Change -15.52% -12.12% -12.12%
Total Long-Term Assets $62.90M $63.22M $63.22M
YoY Change -0.52% 11.45% 11.44%
TOTAL ASSETS
Total Short-Term Assets $2.050M $4.440M $4.440M
Total Long-Term Assets $62.90M $63.22M $63.22M
Total Assets $64.95M $67.66M $67.66M
YoY Change -4.01% 15.49% 15.48%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.350M $1.800M $1.800M
YoY Change -25.0% -14.69% -14.69%
Accrued Expenses $20.00K $40.00K $40.00K
YoY Change -50.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.370M $1.840M $1.840M
YoY Change -25.54% -12.8% -12.8%
LONG-TERM LIABILITIES
Long-Term Debt $23.53M $23.75M $23.75M
YoY Change -0.93% 23.25% 23.25%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $23.53M $23.75M $23.75M
YoY Change -0.93% 23.25% 23.25%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.370M $1.840M $1.840M
Total Long-Term Liabilities $23.53M $23.75M $23.75M
Total Liabilities $24.91M $25.60M $25.60M
YoY Change -2.69% 19.7% 19.74%
SHAREHOLDERS EQUITY
Retained Earnings -$509.9K $1.643M
YoY Change -131.04% -48.12%
Common Stock $93.43K $93.30K
YoY Change 0.14% 21.29%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $40.04M $42.07M $42.07M
YoY Change
Total Liabilities & Shareholders Equity $64.95M $67.66M $67.66M
YoY Change -4.01% 15.49% 15.48%

Cashflow Statement

Concept 2020 Q4 2019 Q4 2019
OPERATING ACTIVITIES
Net Income $320.0K $20.00K $590.6K
YoY Change 1500.0% -75.0% -4.65%
Depreciation, Depletion And Amortization $460.0K $380.0K $1.440M
YoY Change 21.05% 8.57% 2.98%
Cash From Operating Activities $780.0K $110.0K $1.707M
YoY Change 609.09% -86.42% -25.16%
INVESTING ACTIVITIES
Capital Expenditures -$10.00K -$7.300M -$7.780M
YoY Change -99.86% 14500.0% 4762.5%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$10.00K -$7.300M -$7.783M
YoY Change -99.86% 14500.0% 4630.2%
FINANCING ACTIVITIES
Cash Dividend Paid $2.107M
YoY Change 5.77%
Common Stock Issuance & Retirement, Net $6.281M $6.281M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -730.0K 10.09M 8.617M
YoY Change -107.23% -1025.69% -423.83%
NET CHANGE
Cash From Operating Activities 780.0K 110.0K 1.707M
Cash From Investing Activities -10.00K -7.300M -7.783M
Cash From Financing Activities -730.0K 10.09M 8.617M
Net Change In Cash 40.00K 2.900M 2.541M
YoY Change -98.62% -978.79% -567.02%
FREE CASH FLOW
Cash From Operating Activities $780.0K $110.0K $1.707M
Capital Expenditures -$10.00K -$7.300M -$7.780M
Free Cash Flow $790.0K $7.410M $9.487M
YoY Change -89.34% 761.63% 288.63%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2021Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
9356202
CY2020Q2 dei Entity Public Float
EntityPublicFloat
33524029
CY2020 dei Entity File Number
EntityFileNumber
001-12681
CY2020 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
13-3926714
CY2020 dei Entity Address Address Line1
EntityAddressAddressLine1
11 Hanover Square
CY2020 dei Entity Address Address Line2
EntityAddressAddressLine2
12th Floor
CY2020 dei Entity Address City Or Town
EntityAddressCityOrTown
New York
CY2020 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2020 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10005
CY2020 dei City Area Code
CityAreaCode
212
CY2020 dei Local Phone Number
LocalPhoneNumber
785-0900
CY2020 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
CY2020 dei Document Annual Report
DocumentAnnualReport
true
CY2020 dei Document Transition Report
DocumentTransitionReport
false
CY2020 dei Security12b Title
Security12bTitle
Common Stock, $0.01 par value
CY2020 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2019Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
59752153
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3990160
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
263405
CY2019Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
1761312
CY2019Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
164078
CY2019Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
325450
CY2019Q4 us-gaap Debt Issuance Costs Line Of Credit Arrangements Net
DebtIssuanceCostsLineOfCreditArrangementsNet
311869
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
398795
CY2019Q4 us-gaap Goodwill
Goodwill
694121
CY2020Q4 us-gaap Assets
Assets
64945375
CY2019Q4 us-gaap Assets
Assets
67661343
CY2020Q4 us-gaap Notes Payable
NotesPayable
18389176
CY2019Q4 us-gaap Notes Payable
NotesPayable
18839787
CY2020Q4 us-gaap Line Of Credit
LineOfCredit
5144000
CY2019Q4 us-gaap Line Of Credit
LineOfCredit
4914000
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
1373308
CY2019Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
1841640
CY2020Q4 us-gaap Liabilities
Liabilities
24906484
CY2019Q4 us-gaap Liabilities
Liabilities
25595427
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
93431
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
93303
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
40455409
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
40329502
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-509949
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1643111
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
40038891
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
42065916
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
64945375
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
67661343
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
450000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
450000000
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9343118
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9330297
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9343118
CY2020 us-gaap Business Development
BusinessDevelopment
10998
CY2020 us-gaap Operating Expenses
OperatingExpenses
7976312
CY2019 us-gaap Operating Expenses
OperatingExpenses
7267498
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
1400824
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7782687
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
126035
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
102989
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
126035
CY2020 us-gaap Dividends
Dividends
2427401
CY2020 us-gaap Profit Loss
ProfitLoss
274341
CY2019 us-gaap Profit Loss
ProfitLoss
590619
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1997328
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1707330
CY2019 self Payments To Acquire Improvements And Equipment
PaymentsToAcquireImprovementsAndEquipment
58186
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1607346
CY2019 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
4914000
CY2020 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
491081
CY2019 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
470955
CY2019 us-gaap Payments Of Dividends
PaymentsOfDividends
2107376
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2688104
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
8616656
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2298122
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2541299
CY2020 self Payments To Acquire Improvements And Equipment
PaymentsToAcquireImprovementsAndEquipment
203077
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9330297
CY2019 us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
8371292
CY2020 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1989761
CY2019 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1438908
CY2019 us-gaap Business Development
BusinessDevelopment
124428
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
1220212
CY2020 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
79331
CY2019 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
71666
CY2020 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
155139
CY2019 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
193705
CY2020 us-gaap Interest Expense
InterestExpense
1180341
CY2019 us-gaap Interest Expense
InterestExpense
1075576
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-945871
CY2019 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-810205
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9273554
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9282687
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7702117
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
37205876
CY2019 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
6280987
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
102989
CY2019 us-gaap Dividends
Dividends
2114555
CY2019 us-gaap Payments To Acquire Buildings
PaymentsToAcquireBuildings
6287082
CY2020 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
230000
CY2019 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
6280987
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4253565
CY2020Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
358
CY2019Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
7179
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1712266
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1955443
CY2020 us-gaap Interest Paid Net
InterestPaidNet
996904
CY2019 us-gaap Interest Paid Net
InterestPaidNet
821434
CY2020 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Reclassifications</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain amounts from the prior year have been reclassified to conform to current year presentation as described below.</p>
CY2020Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
6671450
CY2019Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
498769
CY2020 us-gaap Nature Of Operations
NatureOfOperations
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">1. ORGANIZATION</p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Global Self Storage, Inc. (the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;our,&#8221; &#8220;us&#8221;) is a self-administered and self-managed Maryland real estate investment trust (&#8220;REIT&#8221;) that owns, operates, manages, acquires, develops and redevelops self storage properties (&#8220;stores&#8221; or &#8220;properties&#8221;) in the United States. <font style="color:#000000;">Through its wholly owned subsidiaries, the Company owns and/or manages 13 self-storage properties in Connecticut</font>, Illinois, Indiana, New York, Ohio, Pennsylvania, South Carolina, and Oklahoma. The Company operates primarily in one segment: rental operations.<font style="color:#000000;"> </font></p>
CY2020 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-align:justify;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. The effects of the COVID-19 pandemic may negatively and materially impact significant estimates and assumptions used by the Company including, but not limited to estimates of expected credit losses and the fair value estimates of the Company&#8217;s assets and liabilities. Actual results could materially differ from management&#8217;s estimates.</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
CY2020 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Credit Risk</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Credit risk - Financial assets that are exposed to credit risk consist primarily of cash and cash equivalents and certain portions of accounts receivable including rents receivable from our tenants. Cash and cash equivalents are on deposit with highly rated commercial banks.</p>
CY2020Q4 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
66439983
CY2020Q4 self Real Estate Investment Buildings Improvements And Equipment
RealEstateInvestmentBuildingsImprovementsAndEquipment
60317918
CY2019Q4 self Real Estate Investment Buildings Improvements And Equipment
RealEstateInvestmentBuildingsImprovementsAndEquipment
57178338
CY2019Q4 us-gaap Development In Process
DevelopmentInProcess
1532235
CY2019Q4 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
64832638
CY2019Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
5080485
CY2019 self Leasable Square Feet
LeasableSquareFeet
16500
CY2020Q4 us-gaap Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
755487
CY2019Q4 us-gaap Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
755487
CY2020Q4 self Equity Securities Unrealized Gain
EquitySecuritiesUnrealizedGain
1160964
CY2019Q4 self Equity Securities Unrealized Gain
EquitySecuritiesUnrealizedGain
1005825
CY2019Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
19338556
CY2020Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
458299
CY2020Q4 self Notes Payable Net
NotesPayableNet
18389176
CY2019Q4 self Notes Payable Net
NotesPayableNet
18839787
CY2020Q4 us-gaap Debt Instrument Collateral Amount
DebtInstrumentCollateralAmount
25900000
CY2020Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
513857
CY2020Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
535816
CY2020Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
558714
CY2020Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
582591
CY2020Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
607488
CY2020Q4 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
16049009
CY2020Q4 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2019Q4 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2020Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
0
CY2019Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
0
CY2020Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
0
CY2019Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
0
CY2016Q2 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
646246
CY2020Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
18847475
CY2020Q4 us-gaap Number Of Stores
NumberOfStores
13
CY2020 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2020 self Percentage Of Real Estate Investment Trust Taxable Income Distributed For Exemption Of Federal Income Tax
PercentageOfRealEstateInvestmentTrustTaxableIncomeDistributedForExemptionOfFederalIncomeTax
0.90
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2020 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2019 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
24972
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
37700
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
24972
CY2019Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
37700
CY2020Q4 us-gaap Operating Lease Liability Statement Of Financial Position Extensible List
OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
us-gaap:OtherLiabilitiesMember
CY2019Q4 us-gaap Operating Lease Liability Statement Of Financial Position Extensible List
OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
us-gaap:OtherLiabilitiesMember
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0478
CY2021Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
14254
CY2022Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
11878
CY2020 self Weighted Average Number Of Shares Outstanding Net Effect Of Dilutive Unvested Restricted Stock Awards Included For Treasury Stock Method
WeightedAverageNumberOfSharesOutstandingNetEffectOfDilutiveUnvestedRestrictedStockAwardsIncludedForTreasuryStockMethod
9133
CY2019 self Weighted Average Number Of Shares Outstanding Net Effect Of Dilutive Unvested Restricted Stock Awards Included For Treasury Stock Method
WeightedAverageNumberOfSharesOutstandingNetEffectOfDilutiveUnvestedRestrictedStockAwardsIncludedForTreasuryStockMethod
2151
CY2020 us-gaap Dividends Common Stock
DividendsCommonStock
2427401
CY2019 us-gaap Dividends Common Stock
DividendsCommonStock
2107376
CY2019 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.26
CY2020 self Reimbursement Of Automobile Expenses
ReimbursementOfAutomobileExpenses
1000
CY2020 self Automobile Reimbursement Amount
AutomobileReimbursementAmount
2254
CY2019 self Automobile Reimbursement Amount
AutomobileReimbursementAmount
3228
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q4 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
6280987
CY2019Q4 self Issuance Of Rights Offering Net Shares
IssuanceOfRightsOfferingNetShares
1601291
CY2019Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
4.18
CY2019Q4 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
832008
CY2019Q4 us-gaap Real Estate And Accumulated Depreciation Initial Cost Of Land
RealEstateAndAccumulatedDepreciationInitialCostOfLand
6122065
CY2019Q4 us-gaap Real Estate And Accumulated Depreciation Initial Cost Of Buildings And Improvements
RealEstateAndAccumulatedDepreciationInitialCostOfBuildingsAndImprovements
53470167
CY2019Q4 us-gaap Real Estate And Accumulated Depreciation Costs Capitalized Subsequent To Acquisition Carrying Costs
RealEstateAndAccumulatedDepreciationCostsCapitalizedSubsequentToAcquisitionCarryingCosts
6211205
CY2019Q4 us-gaap Real Estate And Accumulated Depreciation Carrying Amount Of Land
RealEstateAndAccumulatedDepreciationCarryingAmountOfLand
6122065
CY2019Q4 us-gaap Real Estate And Accumulated Depreciation Carrying Amount Of Buildings And Improvements
RealEstateAndAccumulatedDepreciationCarryingAmountOfBuildingsAndImprovements
59419039
CY2019Q4 us-gaap Real Estate Gross At Carrying Value
RealEstateGrossAtCarryingValue
65541104
CY2019Q4 us-gaap Real Estate Accumulated Depreciation
RealEstateAccumulatedDepreciation
6264236
CY2020 self Aggregate Cost Of Real Estate For Us Federal Income Tax Purposes
AggregateCostOfRealEstateForUSFederalIncomeTaxPurposes
63788287

Files In Submission

Name View Source Status
0001564590-21-017086-index-headers.html Edgar Link pending
0001564590-21-017086-index.html Edgar Link pending
0001564590-21-017086.txt Edgar Link pending
0001564590-21-017086-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
self-10k_20201231.htm Edgar Link pending
self-20201231.xml Edgar Link completed
self-20201231.xsd Edgar Link pending
self-20201231_cal.xml Edgar Link unprocessable
self-20201231_def.xml Edgar Link unprocessable
self-20201231_lab.xml Edgar Link unprocessable
self-20201231_pre.xml Edgar Link unprocessable
self-ex108_269.htm Edgar Link pending
self-ex211_7.htm Edgar Link pending
self-ex231_11.htm Edgar Link pending
self-ex311_6.htm Edgar Link pending
self-ex312_13.htm Edgar Link pending
self-ex321_10.htm Edgar Link pending
self-ex322_8.htm Edgar Link pending
self-ex44_9.htm Edgar Link pending
Show.js Edgar Link pending